Partner-ready onboarding Allergy America presents a low-friction value proposition for medical practices by offering to fund and supply all testing and immunotherapy, enabling practices to add allergy services with no capital investment. This creates a compelling upsell opportunity for primary care, pulmonology, ENT, dermatology, pediatrics, internal medicine, and healthcare systems seeking to expand service lines and drive incremental revenue per patient.

Revenue uplift per patient The model suggests a conservative net revenue per patient of $1,000 to $2,000, which can be a strong selling point when pitching to practice administrators and group practices. Emphasize predictable reimbursement across carriers and the potential to rapidly improve profitability through expanded allergy testing and immunotherapy programs.

Scale through partnerships Target multi-provider practices and health systems as potential partners to unlock broader adoption across networks. The ability to embed allergy services across existing practices can drive volume, referrals, and shared marketing opportunities, aligning with practices looking to differentiate and attract allergy-related patient cohorts.

Technology-enabled delivery Highlight the company’s tech footprint and smooth integration with existing workflows via WordPress, MySQL, Google Workspace, and lightweight tracking. Position Allergy America as a partner that can provide digital scheduling, patient testing logistics, and reporting solutions to reduce administrative burden for partner clinics.

Market demand alignment There is a large unmet need in allergy diagnosis and treatment (less than 1% currently served). This signals substantial growth potential and an attractive addressable market for sales discussions focused on expanding access, increasing awareness among PCPs and specialists, and capturing a share of the growing allergy care market.